Litcius/Paper detail

Women with Fragile X–associated Tremor/Ataxia Syndrome

Andrea Schneider, Scott M. Summers, Flora Tassone, Andreea L. Seritan, David Hessl, Paul J. Hagerman, Randi J. Hagerman

2020Movement Disorders Clinical Practice33 citationsDOIOpen Access PDF

Abstract

ABSTRACT Background Fragile X–associated tremor and ataxia syndrome (FXTAS) is a late‐onset neurodegenerative disorder linked to the FMR1 premutation. Objectives FXTAS in women is far less common than in men, and this study represents the largest sample reported to date. Methods A total of 53 female premutation carriers with FXTAS (mean age , 66.83 years; FXTAS stages 2–5) and 55 age‐matched and demographic background–matched control participants (mean age , 61.94 years) underwent a comprehensive molecular, physiological, neuropsychological, and psychiatric assessment. Results The large sample of female premutation carriers showed a wide range of variability of clinical signs and symptom progression. The imaging results showed a middle cerebellar peduncles sign in only 6 patients; another symptom included high‐signal intensity in the splenium of the corpus callosum, and diffuse cerebral deep white matter changes (e.g., in the pons) are more common. The rate of psychiatric disorders, especially depression, is higher than in the general population. There is a clear impairment in executive functioning and fine motor skills in connection with a higher FXTAS stage. Conclusions The manifestation of FXTAS symptoms in female carriers can be diverse with a milder phenotype and a lower penetrance than those observed in male premutation carriers. The middle cerebellar peduncles sign is present in only a small percentage of the sample, and we propose that the imaging criteria for FXTAS in women need to be expanded.

Topics & Concepts

AtaxiaFMR1NeuropsychologyMedicineSpleniumGait AtaxiaPopulationAudiologyCorpus callosumPediatricsPsychiatryPsychologyWhite matterMagnetic resonance imagingPathologyCognitionGeneticsFragile xBiologyRadiologyEnvironmental healthGeneGenetics and Neurodevelopmental DisordersGenetic Neurodegenerative DiseasesNeurological disorders and treatments